Yuelong Guo (John Guo)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

Transfusion

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

GeneCentric Therapeutics Inc

North Carolina State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GeneCentric Therapeutics Inc Apr 01 2019

United States

Senior Bioinformatics Scientist

RTI International Dec 01 2014 - Mar 31 2019

United States

Research Statistician :: Genomics in Public Health and Medicine

Amgen Inc Jun 02 2014 - Aug 22 2014

United States

Intern :: Discovery Toxicology

Education History

North Carolina State University Jan 05 2011 - May 15 2015

United States

PHD :: Genomics Sciences

North Carolina State University Aug 15 2007 - May 15 2010

United States

MSC :: Plant Biology

Publications

Kirk D Beebe, Joel R Eisner, Yuelong Guo, Yoichiro Shibata, James M Davison, Josh Uronis, Carol J Farhangfar, Farhang Farhangfar, Jill Mooney, Michael V Milburn, Richard L White, Asim Amin, Marcos E Milla, David M Foureau
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Kirk D Beebe, Joel R Eisner, Yuelong Guo, Yoichiro Shibata, James M Davison, Josh Uronis, Carol J Farhangfar, Farhang Farhangfar, Jill Mooney, Michael V Milburn, Richard L White, Asim Amin, Marcos E Milla, David M Foureau
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Kirk D Beebe, Joel R Eisner, Yuelong Guo, Yoichiro Shibata, James M Davison, Josh Uronis, Carol J Farhangfar, Farhang Farhangfar, Jill Mooney, Michael V Milburn, Richard L White, Asim Amin, Marcos E Milla, David M Foureau
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies. Journal of immunology (Baltimore, Md. : 1950) (2024)
Kirk D Beebe, Joel R Eisner, Yuelong Guo, Yoichiro Shibata, James M Davison, Josh Uronis, Carol J Farhangfar, Farhang Farhangfar, Jill Mooney, Michael V Milburn, Richard L White, Asim Amin, Marcos E Milla, David M Foureau
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Kirk D Beebe, Joel R Eisner, Yuelong Guo, Yoichiro Shibata, James M Davison, Josh Uronis, Carol J Farhangfar, Farhang Farhangfar, Jill Mooney, Michael V Milburn, Richard L White, Asim Amin, Marcos E Milla, David M Foureau
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Joel R Eisner, Gregory M Mayhew, James M Davison, Kirk D Beebe, Yoichiro Shibata, Yuelong Guo, Carol J Farhangfar, Farhang Farhangfar, Joshua M Uronis, Jeffrey M Conroy, Michael V Milburn, David Neil Hayes, Kathryn F Mileham
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer - The Piedmont Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Joel R Eisner, Kirk D Beebe, Gregory M Mayhew, Yoichiro Shibata, Yuelong Guo, Carol J Farhangfar, Farhang Farhangfar, Joshua M Uronis, Jill Mooney, Michael V Milburn, David M Foureau, Richard L White, Asim Amin, Marcos E Milla
Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer. Cancer research communications 2 (8) (2022)
Bryan C Quach, Michael J Bray, Nathan C Gaddis, Mengzhen Liu, Teemu Palviainen, Camelia C Minică, Stephanie M Zellers, Richard Sherva, Fazil Aliev, Michael Nothnagel, Kendra A Young, Jesse A Marks, Hannah Young, Megan U Carnes, Yuelong Guo, Alexander M Waldrop, Nancy Y A Sey, Maria Teresa Landi, Daniel W McNeil, Dmitriy Drichel, Lindsay A Farrer, Christina A Markunas, Jacqueline M Vink, Jouke- Jan Hottenga, William G Iacono, Henry R Kranzler, Nancy L Saccone, Michael C Neale, Pamela Madden, Marcella D C Rietschel, Mary L Marazita, Matthew McGue, Hyejung Won, Georg Winterer, Richard Grucza, Danielle M Dick, Joshua C Gray, Neil E Caporaso, Timothy B Baker, Dorret I Boomsma, Jaakko A Kaprio, John E Hokanson, Scott I Vrieze, Laura J Bierut, Eric O Johnson, Dana B Hancock
Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits. Nature communications 11 (1) (2020)
Yuelong Guo, Michael P Busch, Mark Seielstad, Stacy Endres-Dighe, Connie M Westhoff, Brendan Keating, Carolyn Hoppe, Aarash Bordbar, Brian S Custer, Adam S Butterworth, Tamir Kanias, Alan E Mast, Steve Kleinman, Yontao Lu, Grier P Page, null null
Development and evaluation of a transfusion medicine genome wide genotyping array. Transfusion 59 (1) (2018)

Yuelong Guo.css-eqlu8i{font-size:small;padding-left:4px;} (John Guo)

Publication Activity (10 Years)

Top Topics

Top Venues

Yuelong Guo (John Guo)